FDA Submits Proposed Collection of Information for Review and Clearance Under Paperwork Reduction Act of 1995

Summary

The Food and Drug Administration (FDA) is announcing a proposed collection of information for review and clearance under the Paperwork Reduction Act of 1995, with the goal of supporting the use of symbols on labels and in labeling of in vitro diagnostic devices intended for professional use.